EN
HI
Sandu Pharmaceuticals Share Price
SANDUPHQ
370.24 (0.65%)
Last updated on 18 Sep, 2026 | 16:01 IST
Free Demat with Zero AMC*
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
Summary
As of 21 Sep, 2026, Sandu Pharmaceuticals stock price is ₹37. During the trading session, the stock has moved between an intraday low of ₹36.45 and an intraday high of ₹37.35. Over the last 52 weeks, Sandu Pharmaceuticals has traded between ₹30.00 and ₹50.00.
The stock has recorded a trading volume of 225 shares,. Its Average Traded Price (ATP) is ₹36.76, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 100 @ ₹37.00.
Sandu Pharmaceuticals has an upper circuit limit of ₹44.40 and a lower circuit limit of ₹29.60. The total value traded stands at ₹8271.00, and the delivery percentage for the day is 99.79%.
The stock is currently traded with a market lot size of 1. Sandu Pharmaceuticals also offers a dividend yield of 2.7%.
Sandu Pharmaceuticals Share Price Chart
Sandu Pharmaceuticals Share Key Metrics
Volume
225.00
Market Cap
35.75 CR
LTQ@LTP
100@37.00
ATP
36.76
Var Margin
25 %
Circuit Range
29.6-44.4
Delivery %
99.79 %
Value
8271.00
ASM/GSM
No
Market Lot
1
Sandu Pharmaceuticals Resistance and Support
Pivot 37.04
Resistance
First Resistance
37.71
Second Resistance
38.65
Third Resistance
39.32
Support
First Support
36.1
Second Support
35.43
Third Support
34.49
Sandu Pharmaceuticals Shareholding Pattern
View More- 2018-19
- 2019-20
- 2022-23
- 2023-24
- 2024-25
- 2025-26
- 2026-27
- 2021-22
- 2020-21
Total Promoters
Segment
Percent
Total Promoters
48.02%
Mutual Fund
0%
Insurance
0%
Foreign Institutional Investors
0%
Domestic Institutional Investors
0.01%
Retail
51.97%
Others
0%
Total Promoters
MAR '21
45.04%
JUN '21
45.04%
SEP '21
45.04%
DEC '21
48.02%
Sandu Pharmaceuticals Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-11 | Quarterly Results |
| 2026-07-11 | Others |
| 2026-05-05 | Audited Results & Final Dividend |
| 2026-02-06 | Quarterly Results |
| 2025-11-12 | Quarterly Results |
| 2025-10-14 | Others |
| 2025-08-13 | Quarterly Results |
| 2025-05-28 | Audited Results & Final Dividend |
| 2025-02-13 | Quarterly Results |
| 2024-11-14 | Quarterly Results |
| 2024-08-12 | Quarterly Results & Final Dividend |
| Ex Date | Record Date | |
|---|---|---|
| 2026-09-04 | 2026-09-04 | View More |
Sandu Pharmaceuticals Management
| Name | Position |
|---|---|
| Balram Viswanathan | Chairman & Non Executive Independent Director |
| Ajit R Kantak | Non Executive Independent Director |
Sandu Pharmaceuticals Similar Stocks
Global Longlife Hospital and Research Ltd.
14.93
0.70 (4.92%)
Bandaram Pharma Packtech Ltd.
20.99
0.21 (1.01%)
Phaarmasia Ltd.
88.00
-1.00 (1.12%)
Adeshwar Meditex Ltd.
16.35
0.00 (0.00%)
KK Shah Hospitals Ltd.
44.00
0.00 (0.00%)
Gujarat Terce Laboratories Ltd.
36.70
-1.05 (2.78%)
Zenith Health Care Ltd.
3.20
-0.08 (2.44%)
GKB Ophthalmics Ltd.
62.50
0.00 (0.00%)
Sandu Pharmaceuticals FAQs
The Buying Price of Sandu Pharmaceuticals share is 37 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Sandu Pharmaceuticals stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Sandu Pharmaceuticals, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Sandu Pharmaceuticals shares is 23.03. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Sandu Pharmaceuticals shares is 1.07. Useful to assess the stock's value relative to its book value.
To assess Sandu Pharmaceuticals’s valuation compare Sector P/E, P/B which are 42.35 & 3.61 with sector averages, along with growth rates and financial metrics.
The Market Cap of Sandu Pharmaceuticals is 35.75 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Sandu Pharmaceuticals share price is 50.00 & 30.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Sandu Pharmaceuticals belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year
Auto Square Off Charges
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools

Open Your Free
Demat Account Now!
AMC For First Year
Account Opening Fee
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools
Invest in SANDUPHQ
Account Opening Fee
AMC for 1st Year
Auto Square Off Charges
Call & Trade
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC